drugset / Trial / NCT00973271
Diazoxide Choline Controlled-Release Tablet (DCCR) for Very High Triglycerides
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The hypothesis of this study is that DCCR is effective as both monotherapy and in combination with a statin in lowering triglycerides in subjects with very high triglycerides
Timeline
- Start
- 2011-03
- Primary completion
- 2011-11
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Diazoxide Choline | Unknown | 290 mg | — |
| Subject | Diazoxide Choline | Unknown | 435 mg | — |
| Comparator | fenofibric acid | Small molecule | 135 mg | — |
| Background | Atorvastatin | Small molecule | 20 mg | — |